Background: National Institutes of Health Stroke Scale is the most common scale used in stroke patients. An increase of four points or more within 24 h signifies early neurological deterioration. We aimed to establish how often early neurological deterioration occurs in a cohort selected by magnetic resonance imaging and which factors predicted early neurological deterioration.
Introduction
Acute recanalization therapy with either intravenous (IV) tissue plasminogen activator (tPA) or by intra arterial therapy (IAT) improves outcome in acute ischemic stroke. 1, 2 Patients may deteriorate after the administration of IV tPA. An increase on the National Institutes of Health Stroke Scale (NIHSS) of four points or more has been utilized to define significant deterioration. 3 If this occurs within the first 24 h, it is defined as early neurological deterioration (END). There are several reasons for this, but the most feared is symptomatic intracerebral hemorrhage (sICH).
In a recent review, END was present in 13.8% of IV tPA-treated patients, and 20% of these were caused by sICH. Predictors of END have included hyperglycemia, absence of antiplatelet therapy and arterial stenosis. 4 An overview of the literature has shown that perfusion abnormalities likely play a role in END 5 and a recent study found that a penumbra predicted END in patients that did not receive IV tPA. 6 We retrospectively examined our institutional database of patients who were evaluated by acute magnetic resonance imaging (MRI), to establish how often END occurred, what the causes were and if a large perfusion lesion would predict END.
Materials and methods

Study design
This is a single-center cohort study evaluating consecutive patients undergoing reperfusion therapy for acute ischemic stroke. Data were collected prospectively for treated patients. The study was approved by the Danish Data Protection Agency (journal number 2012-41-1185). According to Danish law, approval from The Ethic Committee is not required for studies based on clinical registries.
Population
Patients treated between 2004 and 2010 were included in this analysis. Eligible patients were treated with IV tPA according to national clinical guidelines during the study period. Patients included had to be 18-80 years of age, with an acute, focal neurological deficit, hemorrhage excluded and treatment initiated less than 3 h after symptom onset. A diffusion-weighted imaging (DWI) lesion larger than a third of the middle cerebral artery (MCA) territory was an additional exclusion criterion for IV tPA. No upper or lower NIHSS threshold was applied. The treatment window was extended to 4.5 h from January 2010, when the upper age limit of 80 years was also eliminated following a change in national guidelines.
Imaging parameters
MRI is the preferred imaging modality for patients presenting with symptoms of acute stroke at our hospital. Only in cases of a contraindication to MRI (e.g., pacemaker), if the patient is too unstable (e.g., vomiting, respiratory concerns) or if the patient can not fit into the MRI scanner (e.g., obesity, severe cervical kyphosis) a computed tomography scan is obtained. MRI was done on either a 3.0-or 1.5-Tesla scanner. The MRI protocol included DWI, T2*-weighted imaging and fluid-attenuated inversion recovery imaging. Magnetic resonance angiography was only done when large vessel occlusion was suspected and hence not done routinely. Dynamic susceptibility contrast PWI during infusion of a bolus of Gadolinium-based contrast agent was performed unless there was a medical contraindication (e.g., kidney failure) or treatment time window was closing. Absent PWI data could also result from technical error during the scan or subcutaneous infusion of contrast. Detection and delineation of the DWI and perfusion abnormality were done by an experienced neuroradiologist and neurologist nonblinded to lesion side. Penumbra was defined as voxels with Tmax > 6 s within the time-to-peak abnormality but outside the DWI lesion.
We used the most common definition of penumbra as a perfusion deficit of at least 10 cc and at least 20% larger than the DWI lesion. 7 We also examined other definitions on penumbra as described under Results.
Follow-up
Per hospital protocol, all patients were assessed using NIHSS on admission, 2 h after IV tPA administration and 24 h after. END was said to have occurred if the 24 h NIHSS score was four point or more higher than the initial score. NIHSS scoring was performed by neurologists as part of clinical routine.
Imaging was repeated 22-36 h post-treatment and evaluated by a neuroradiologist (MHM) and neurologist (CZS or MLS). The SITS-MOST definition of sICH was applied. 8 (Local or remote parenchymal hemorrhage type 2 on the 22-36 h post-treatment scan combined with an increase of four points or more on NIHSS.) Extension of the infarct was also evaluated on this scan.
The patients were seen in the outpatient clinic at approximately 90 days after the stroke to establish outcome using the modified Rankin scale (mRS), and the etiologic stroke subtype was determined according to the TOAST criteria. 9 
Statistical analysis
Standard descriptive statistics were used to summarize the baseline clinical and imaging variables. The Chisquare test was used for categorical variables. The Kruskal-Wallis test was used to compare continuous variables comparing more than two groups, and the Mann-Whitney test was used when there were only two groups. The association between potential predictors and END was examined using logistic regression. Significant (p < 0.05) univariate predictors of END were identified and entered in a multivariable logistic regression. Receiver operating characteristic (ROC) analysis was done to find the optimal perfusion lesion that predicted END. Statistical significance was defined at twotailed p value < 0.05. All analyses were performed using MedCalc software (version 14.12.0, Ostend, Belgium).
International Journal of Stroke, 11 (7) Results A total of 569 patients received reperfusion therapy based on clinical and MRI criteria during the inclusion period and were included in the analysis. All received IV tPA and 46 also received IAT. PWI was obtained in 464 patients. Median NIHSS for all patients was 7 (interquartile range (IQR) 4-12) before treatment and 3 (IQR 0-7) after 24 h.
Thirty-three patients (5.8%) experienced END, as defined by an increase of four points or more on NIHSS. In seven of these (21%), the cause was sICH. Three had worsening due to small vessel disease (two in basal ganglia and one in the pons), and 23 had visible extension of the infarct. The majority had extension within an already affected territory. One patient undergoing IAT had an infarct in the opposite hemisphere on follow-up imaging, which was most likely an embolic complication of the treatment. One patient had initially a MCA infarct and had extension in the MCA and posterior cerebral artery territory, and three had extension from the MCA to the MCA and anterior cerebral artery territory in the same hemisphere. Two patients had early swelling secondary to infarct growth. Figure 1 shows a typical patient. END can also occur secondary to medical conditions (e.g. fever and seizure) but we did not observe this in our cohort.
As shown in Table 1 , no vascular risk factor (age, diabetes, hypertension, atrial fibrillation, hyperlipidemia or smoking) identified patients at risk for END. There were no differences in presenting NIHSS or systolic blood pressure between patients with and without END. Patients with END had higher levels of blood glucose. Comparing the mean blood glucose of the patients without END (6.3 mmol/L, IQR 5.8-7.3) with the patients with END (6.8 mmol/L, IQR 6.4-7.9), there was a significant difference (p ¼ 0.01). Also, prior aspirin use was more prevalent in the group with END due to sICH (p ¼ 0.03) but not in the group with END due to ischemia (p ¼ 0.50) compared to the non-END group.
Stroke etiology, according to the TOAST criteria, was not significant in predicting END (p ¼ 0.05). Comparing END within each etiology, large vessel disease (LVD) came out as the only one significantly related to END (p ¼ 0.03). In this respect, it is noteworthy that all seven patients with sICH had either LVD (four patients) or cardiac emboli (three patients) and that all four patients with END from ''other'' causes were dissections.
There were no significant differences in the size of the acute DWI lesion or the interval from symptom onset to scan between the patients with and without END. Logistic regression identified PWI lesion, glucose level and LVD as significant predictors of END. A multivariable logistic regression including these predictors revealed that PWI lesion was the best in predicting END (p ¼ 0.0002) followed by glucose level (p ¼ 0.01) and presence of LVD (p ¼ 0.04).
We examined how reliable the penumbra was in predicting END. Using the definition of a perfusion lesion being at least 10 cc and at least 20% larger than the Figure 1 . A 63-year-old male with no prior medical history was admitted with a slight right-sided hemiparesis and aphasia, National Institute of Health Stroke Scale (NIHSS) was 5. (a) A small diffusion lesion is seen in cortex of the right insula (white arrow). (b) Hypoperfusion is seen in the territory of the posterior branch of the middle cerebral artery. The patient progressed over the next 24 h and developed severe aphasia. NIHSS after 24 h was 14. On follow-up imaging, the infarct had progressed to the more anterior region of the middle cerebral artery and the basal ganglia (c). A dissection was found as the etiology for the stroke. DWI, 159 patients had a penumbra, but only 15 of these had END, giving a positive predictive value of penumbra of 15/159 ¼ 9.4%. Sensitivity and specificity of penumbra in predicting END was 15/25 ¼ 60.0% and 295/439 ¼ 67.2%, respectively (Table 2) .
Changing the penumbra definition to a deficit of at least 80% larger than the diffusion deficit, the positive predictive value of penumbra increased slightly to 15/134 ¼ 11.2%. Sensitivity and specificity were now 60.0% vs. 72.9% (Table 2) .
We performed an ROC analysis (not shown) to find the optimal perfusion lesion that predicted END, regardless of the DWI lesion. A perfusion lesion > 35 cc predicted END with a sensitivity of 76% and a specificity of 71%. Using this cut off, positive predictive value increased slightly to 19/149 ¼ 12.8% (Table 2 ).
In the absence of vessel status, a large perfusion lesion would serve as a surrogate for large vessel occlusion. A perfusion lesion larger than 50 cc had a lower sensitivity of 15/25 ¼ 60.0% and a slightly higher International Journal of Stroke, 11 (7) specificity of 338/439 ¼ 77.0% in predicting END ( Table 2) . Limiting the analysis to only IV tPA treated or only anterior circulation strokes did not change the results.
END proved a poor prognostic factor. The odds ratio for disability or death (mRS > 2) was 14.9 (95% confidence interval: 6.5-34.0). Odds ratio for death was 38.8 (95% confidence interval: 15.3-98.4).
Discussion
In this study of patients selected with MRI for reperfusion therapy, END was relatively rare, occurring in only 6% of cases. While the most feared complication after reperfusion therapy is sICH, the most frequent reason for END was extension of the infarct. Figure 1 shows the imaging evolution for a typical patient. This neurological worsening was not predicted by any clinical factors, but hyperglycemia, a large PWI lesion and LVD were related to END.
Our findings are generally in line with previous publications. A recent review of a variety of trials shows END in IV tPA-treated patients in 13% of cases, 21% caused by sICH. The strongest predictors of END were hyperglycemia, no aspirin use, prior transient ischemic attacks and arterial occlusion. 4 Our rate of END is lower than that found in the literature. The mean NIHSS in our study was seven and thus lower than others. A Japanese study, where the mean NIHSS was 13, found END in 9.9% of 566 stroke patients with only 12.5% of END caused by sICH. Interestingly, in Japan the tPA dose is only 0.6 mg/kg, two-thirds of the dose that we typically use. High blood glucose, lower initial NIHSS and internal carotid occlusion predicted END in their series. 10 We excluded patients with large infarcts on DWI from treatment, a group at significant risk for deterioration due to edema or secondary hemorrhage, 11 likely making risk of END smaller in our cohort. We did not find a relationship between NIHSS and END, but both lower NIHSS 10 and higher NIHSS have been related to END. 12 In a study by Seners et al., 13 END occurred in 11% of their MRI-selected patients, but these patients were also severely affected, with a mean NIHSS of 15. Their findings suggested an association between END and no prior antiplatelet treatment, higher blood glucose, lower NIHSS and a larger DWI-PWI mismatch. The authors conclude that the cause of END is likely extension of the infarct, which they were able to demonstrate in 10 out of 33 patients and state that endovascular therapy may be attractive in the face of END. 14 ''Rescue IAT'' has been tried with success in a population where END was defined as an increase of only 1 on NIHSS. 15 Here, IAT was independently associated with a good outcome.
Balancing hemorrhagic and ischemic risk has long presented a challenge in stroke care, and END is no exception. Mechanistically, penumbral loss leading to ischemia may relate to failure to maintain vessel patency of secondary collateral channels. Prior use of aspirin may be protective against END, 4 but our study found a risk of sICH with prior aspirin use. The role of antiplatelet therapy together with IV tPA was tested in the ARTIS trial, where it was seen that more patients experienced sICH after early aspirin treatment. 16 In this study, 4.8% experienced END, half due to sICH. A post-hoc analysis found that early aspirin increased the risk for END due to sICH, but not due to ischemia. Again, hyperglycemia was related to END due to ischemia. 17 Interestingly, it has been shown that it is only non-diabetics with elevated blood glucose that experience deterioration in terms of infarct growth, while diabetics do not. 18 The presence of a penumbra is generally a marker of better response to IV tPA and a better chance of remission of symptoms, 19 which we also find; the penumbra group as a whole experienced a drop in 24 h NIHSS of four points, compared to only two points in the nonpenumbral group, which was statistically significant. However, the reduced cerebral blood flow of the penumbra may progress to infarction in patients with suboptimal recanalization. This suggests that penumbra might help to predict END. Among the 464 patients where PWI was performed, 34% had penumbral pattern but only 9% of these patients had END. The presence of a penumbra was relatively common, and the ability to predict END is diluted by the numerous patients that either have benign oligemia or successfully reperfuse spontaneously or after treatment. It is a limitation to our study that we do not have vessel status before and after treatment in order to evaluate this. Further limitations are lack of blinded NIHSS assessment, and problems inherent to a single center, retrospective analysis of a prospectively collected observational dataset.
An ultrasound study found vascular occlusion (either inability to recanalize with IV tPA or re-occlusion) the best predictor for END, 20 findings which was confirmed in an MRI study. 21 Hence, it is not surprising that we find LVD and large penumbra associated with END. In particular, occlusion of the posterior circulation has been shown to predict deterioration. 22 With recent trial data demonstrating the benefit of IAT, the argument could be constructed that a low treatment threshold should be considered for patients with proximal occlusions and penumbral tissue, even in the presence of a good clinical examination. In MR CLEAN, the presence of an occluded artery was used as selection criteria for IAT regardless of NIHSS. 2 Finally, the routine use of MRI for revascularization decisions has not gained widespread acceptance as an acute stroke tool, primarily for logistic reasons. Therefore, while the sensitivity of MRI permits specific evaluation of a variety of clinical questions, our results may not be readily generalizable.
Conclusion
END is rare, but when it occurs is more likely to be caused by extension of ischemia than hemorrhagic complications. Clear clinical predictors of risk are lacking, but concern should be highest in patients with elevated blood glucose, larger perfusion lesions and LVD. Prior aspirin use is a risk factor for sICH.
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